Cellular and Molecular Mechanisms of Low Cardiac Output Syndrome after Pediatric Cardiac Surgery
- PMID: 26463990
- DOI: 10.2174/1570161113666151014122557
Cellular and Molecular Mechanisms of Low Cardiac Output Syndrome after Pediatric Cardiac Surgery
Abstract
Several cellular and molecular mechanisms have been implicated in the development of myocardial dysfunction and low cardiac output in pediatric patients undergoing heart surgery. Ischemia- reperfusion injury with alterations in calcium homeostasis as well as mitochondrial function has been strongly related to myocyte damage and heart failure in this population. In this article, we will review the main mechanisms of postoperative cardiac dysfunction at cellular and molecular levels and the subsequent protective strategies. In addition, we will describe cellular features of the neonatal or immature myocardium and will suggest possible protective management strategies. This article addresses the first of eight topics comprising the special issue entitled "Pharmacologic strategies with afterload reduction in low cardiac output syndrome after pediatric cardiac surgery".
Similar articles
-
Pathophysiology of Post-Operative Low Cardiac Output Syndrome.Curr Vasc Pharmacol. 2016;14(1):14-23. doi: 10.2174/1570161113666151014123718. Curr Vasc Pharmacol. 2016. PMID: 26463989 Review.
-
Pulmonary Vasodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.Curr Vasc Pharmacol. 2016;14(1):37-47. doi: 10.2174/1570161113666151014124912. Curr Vasc Pharmacol. 2016. PMID: 26463986 Review.
-
A Review of Systemic Vasodilators in Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery.Curr Vasc Pharmacol. 2016;14(1):29-36. doi: 10.2174/1570161113666151014124459. Curr Vasc Pharmacol. 2016. PMID: 26463987 Review.
-
Inodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.Curr Vasc Pharmacol. 2016;14(1):48-57. doi: 10.2174/1570161113666151014125314. Curr Vasc Pharmacol. 2016. PMID: 26463985 Review.
-
Thematic Issue: Pharmacologic Strategies with Afterload Reduction in Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.Curr Vasc Pharmacol. 2016;14(1):3-4. doi: 10.2174/157016111401151126162649. Curr Vasc Pharmacol. 2016. PMID: 26642871 No abstract available.
Cited by
-
Predictors of Low Cardiac Output Syndrome in Infants After Open-Heart Surgery.Front Pediatr. 2022 Mar 10;10:829731. doi: 10.3389/fped.2022.829731. eCollection 2022. Front Pediatr. 2022. PMID: 35359906 Free PMC article.
-
Risk factors of postoperative low cardiac output syndrome in children with congenital heart disease: A systematic review and meta-analysis.Front Pediatr. 2023 Jan 10;10:954427. doi: 10.3389/fped.2022.954427. eCollection 2022. Front Pediatr. 2023. PMID: 36704129 Free PMC article. Review.
-
Population Pharmacokinetics of Vancomycin in the Pediatric Cardiac Surgical Population.J Pediatr Pharmacol Ther. 2019 Mar-Apr;24(2):107-116. doi: 10.5863/1551-6776-24.2.107. J Pediatr Pharmacol Ther. 2019. PMID: 31019403 Free PMC article.
-
Effect of cardiopulmonary bypass reoxygenation on myocardial dysfunction following pediatric tetralogy of Fallot repair.BMC Cardiovasc Disord. 2021 Apr 26;21(1):210. doi: 10.1186/s12872-021-02033-2. BMC Cardiovasc Disord. 2021. PMID: 33902450 Free PMC article.
-
Calcium Responsive Pediatric Septic Shock Refractory to Isotonic Crystalloids and Inotropic Agents.J Pediatr Pharmacol Ther. 2022;27(8):765-769. doi: 10.5863/1551-6776-27.8.765. Epub 2022 Nov 17. J Pediatr Pharmacol Ther. 2022. PMID: 36989008 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical